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Abstract
Background: Standard extracellular cardiovascular magnetic resonance (CMR) contrast agents (CA) do not provide 
differentiation between acute and older myocardial infarcts (MI). The purpose of this study was to develop a method 
for differentiation between acute and older myocardial infarct using myocardial late-enhancement (LE) CMR by a new, 
low molecular weight contrast agent.
Dogs (n = 6) were studied in a closed-chest, reperfused, double myocardial infarct model. Myocardial infarcts were
generated by occluding the Left Anterior Descending (LAD) coronary artery with an angioplasty balloon for 180 min,
and four weeks later occluding the Left Circumflex (LCx) coronary artery for 180 min. LE images were obtained on day
3 and day 4 after second myocardial infarct, using Gd(DTPA) (standard extracellular contrast agent) and Gd(ABE-
DTTA) (new, low molecular weight contrast agent), respectively. Triphenyltetrazolium chloride (TTC)
histomorphometry validated existence and location of infarcts. Hematoxylin-eosin and Masson's trichrome staining
provided histologic evaluation of infarcts.
Results: Gd(ABE-DTTA) or Gd(DTPA) highlighted the acute infarct, whereas the four-week old infarct was visualized by 
Gd(DTPA), but not by Gd(ABE-DTTA). With Gd(ABE-DTTA), the mean ± SD signal intensity enhancement (SIE) was 366 ± 
166% and 24 ± 59% in the acute infarct and the four-week old infarct, respectively (P < 0.05). The latter did not differ 
significantly from signal intensity in healthy myocardium (P = NS). Gd(DTPA) produced signal intensity enhancements 
which were similar in acute (431 ± 124%) and four-week old infarcts (400 ± 124%, P = NS), and not statistically different 
from the Gd(ABE-DTTA)-induced SIE in acute infarct. The existence and localization of both infarcts were confirmed by 
triphenyltetrazolium chloride (TTC). Histologic evaluation demonstrated coagulation necrosis, inflammation, and 
multiple foci of calcification in the four day old infarct, while the late subacute infarct showed granulation tissue and 
early collagen deposition.
Conclusions: Late enhancement CMR with separate administrations of standard extracellular contrast agent, 
Gd(DTPA), and the new low molecular weight contrast agent, Gd(ABE-DTTA), differentiates between acute and late 
subacute infarct in a reperfused, double infarct, canine model.
Background
Reinfarction occurs in 7-8% of cardiac patients with pre-
vious MI [1,2]. In a recent meta-analysis [3], with 6921
patients with MI treated primarily with balloon angio-
plasty with or without stenting, the rate of reinfarction
was ~3% in the first year. Differentiation between acute
and older MIs is of great importance in clinical decision-
making. Wall motion abnormalities detected with
echocardiography, computed tomography (CT), or car-
diovascular magnetic resonance (CMR) are not restricted
to acute events. Also, regardless of age of MI, radioactive
tracers are not taken up by non-viable myocardial cells
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imaging, and therefore both recent and long-standing MI
appears as a fixed defect. Not even late enhancement (LE)
CMR with standard extracellular contrast agents (CA)
like Gadolinium-DTPA (Gadolinium-Diethylenetri-
aminepentaacetic acid) differentiates by age of infarct
[4,5].
We have developed a family of CAs for CMR diagnosis
of ischemic heart disease (IHD) [6-9]. Among these,
Gd(ABE-DTTA) is optimal for cardiovascular purposes.
Gd(ABE-DTTA), which is still under investigation, is the
Gadolinium complex of N-(2-butyryloxyethyl)-N'-(2-eth-
yloxy-ethyl)-N, N'-bis [N", N"-bis(carboxymethyl)acet-
amido]-1,2-ethanediamine. This low molecular weight
(764 Dalton) agent's clearance from the blood has a kinet-
ics similar to that of blood pool contrast agents, although
it also displays partly extracellular characteristics [10]. It
demonstrates high affinity for acute MI [10]. The acutely
infarcted tissue takes up Gd(ABE-DTTA) within a longer
period of time than it does purely extracellular contrast
agents. The maximum concentration of the agent in the
acutely infarcted tissue shows up at 48 hr, although it is
not significantly different from that which is already
achieved at 24 hr, and the contrast remains detectable in
the infarct up to 12 days [10]. The agent causes no delete-
rious physiological effects, and a previous study has dem-
onstrated the short- and long term safety of its usage [11].
Gd(ABE-DTTA) has been successfully used for contin-
uous detection of myocardial ischemia during 30 min of
left anterior descending coronary artery (LAD) occlusion
[12,13]. The suitability of Gd(ABE-DTTA) for accurate
quantification of acute MI has also been demonstrated
[14,15].
I n  t h i s  s t u d y  w e  h a v e  s h o w n  t h a t  G d ( A B E - D T T A )
induces a LE effect in acute, but not in late subacute MI.
Methods
Gd(ABE-DTTA) sample preparation
Gd(ABE-DTTA) was synthesized, and samples were pre-
pared, as described by Saab et al. [8]. To guarantee consis-
tent quality of agent before administration the in vitro
relaxivity was measured for every sample [8]. Each animal
received Gd(ABE-DTTA) at the dose of 0.05 mmol/kg,
the in vitro relaxation enhancement of which was equiva-
lent to that of Gd-DTPA at its conventional dose (0.2
mmol/kg) used for LE-CMR.
Study design
Animals were studied with a closed-chest, reperfused,
double MI protocol described below. The smallest num-
ber of animals (n = 6) that still achieved statistical signifi-
cance was used. MIs were generated in the LAD coronary
artery territory and four weeks later in that of the left cir-
cumflex coronary artery (LCx) (Figure 1.). To avoid a con-
founding, simultaneous action of the two contrast agents,
two separate CMR sessions were carried out 3 and 4 days
after the generation of the second MI, separately using
Gd(DTPA) and Gd(ABE-DTTA) in these two sessions,
respectively.
Surgical procedure
Animal protocol was approved by the University of Ala-
bama at Birmingham IACUC in full compliance with the
'Guidelines for the Care and use for Laboratory Animals'
(NIH). Six male hounds (18-20 kg) were used. Twelve
hours prior to procedure food was taken away and 325
mg Aspirin given. Dogs were anesthetized with a Ket-
amine (5.0 mg/kg) and Diazepam(0.5 mg/kg) mixture,
intubated, and connected to a Hallowell EMC Model
2000 respirator (Pittsfield, MA, USA) operated with a
tidal volume of 400 ml at a rate of 16 BPM. Anesthesia
was maintained by continuous Isoflurane (2.5-3 volume
%), and repeated Fentanyl (50-100 ug I.V. every 30 min-
utes), administration. Heart rate and blood oxygen satu-
ration were monitored using a pulse-oxymeter placed on
the animal's tongue. ECG electrodes were placed on the
chest to record electrophysiological signs of myocardial
ischemia and arrhythmias. The left femoral artery was
separated surgically and an arterial sheath (6-8 French)
was inserted. An I.V. line was placed to administer infu-
sion and drugs. Heparin (100 IU/kg) was given intrave-
nously to maintain the activated clotting time (ACT)
above 300 seconds. A properly sized 2-3 mm angioplasty
balloon was introduced under fluoroscopic guidance into
the LAD (1st infarct) or the LCx (2nd infarct) and inflated
for 180 minutes to create MI. Thereafter, the balloon was
deflated to restore coronary circulation. Coronary
angiography confirmed the reperfusion after balloon
deflation.
On days 3 and 4 after the second infarction, animals
were re-anesthetized as described above and CMR stud-
ies performed. Animals were then sacrificed, hearts
excised and embedded in agar. The agar block was cut
perpendicular to the long axis with a commercial meat
slicer into 5 mm sections starting from the apex. 2,3,5-tri-
phenyltetrazolium chloride (TTC) was dissolved in phys-
iological saline to obtain 2% TTC solution. Slices were
immersed in it at 37°C for 15 min and then rinsed with
physiological saline. All TTC-stained slices were photo-
graphed with a high resolution digital camera. TTC-
stained slices were used to validate the existence and
location of infarcts.
Magnetic Resonance Imaging
A 1.5T GE Signa-Horizon CV/i scanner (Milwaukee, WI,
USA) was used. A cardiac phased-array coil and ECG gat-
ing were employed. Breath-hold was performed at end-
expiration. A 180°-prepared, segmented, inversion-recov-
ery fast gradient-echo pulse was used with: Field of ViewKirschner et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:22
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(FOV) 30 cm, Echo Time (TE) 3.32 ms, Repetition Time
(TR) two cardiac cycles (1100-1600 ms), slice thickness
10 mm. The Inversion Time (TI) was optimized to null
the signal normal myocardium. Conventional cardiac
angulation planes were set and short axis slices covering
the entire left ventricle (LV) obtained (six slices per
heart).
In the first CMR session, a 0.2 mmol/kg Gd(DTPA)
(Magnevist, Schering, Kenilworth, NJ) bolus was admin-
istered intravenously. LE images were acquired 15-20 min
thereafter. Gd(ABE-DTTA) was given intravenously at
the end of the first CMR session. In the second CMR ses-
sion, 24 h after Gd(ABE-DTTA) administration, LE
images were similarly obtained.
Histology
Post mortem tissue samples from the infarct and the peri-
infarct regions were examined by histopathology. The
samples were fixed in 10% formalin, embedded in paraf-
fin, and sectioned at 5 μm thickness. Hematoxylin-eosin
and Masson's trichrome staining was performed.
Image analysis
The existence of both acute and four-week old infarcts
was validated and their anatomical localization deter-
mined by analyzing the TTC images. CMR Dicom images
were imported as image sequences with the use of ImageJ
(Wayne Rasband, NIH). The endo- and epicardial con-
tours of the LV muscle were traced manually and this cir-
cumscribed area was further analyzed. Based on the
apicobasal localization and anatomical landmarks (LV
and papillary muscle shape, and the position of the ante-
rior and posterior interventricular grooves), CMR images
acquired in the presence of the two different contrast
agents, as well as the TTC slices, were matched. All CMR
slices that contained a MI according to the corresponding
TTC slices were categorized into four groups by anatomi-
cal localization of the infarct to either the four-week old
or to the acute category, and by the contrast agent given.
To separate the acute and the four-week old infarcts for
the analysis, the images of slices containing both types of
MI were partitioned into two images, each reflecting one
half of the tomographic slice. The partition was done,
with ImageJ, along a straight line starting at the posterior
interventricular groove (0° on the LV circumference),
through the center point of the LV slice, ending at the
180° point on the LV circumference in the anterolateral
r e g i o n .  T h u s  f o u r  g r o u p s  o f  i m a g e s  w e r e  o b t a i n e d  f o r
analysis: Gd(DTPA)acute, Gd(DTPA)4 week, Gd(ABE-
DTTA)acute, Gd(ABE-DTTA)4 week, to which two control
groups, (Gd(DTPA)normal, Gd(ABE-DTTA)normal), i.e. nor-
mal myocardium with each of the two agents, have been
added, bringing the number of data groups for analysis to
six.
To avoid observer bias, instead of manual contouring of
the infarct and the healthy myocardial regions, a pixel-by-
pixel analysis was performed. The pixel-by-pixel SI histo-
gram of every CMR image, segmented in the above man-
ner, was generated with ImageJ and these histograms
were used for further analysis. First, the mean SI ± SD of
healthy myocardium was determined by exporting the
histograms to Origin 7.0 (OriginLab Corporation, Massa-
chusetts, USA), and employing Gaussian curve fitting on
each using the Levenberg-Marquardt algorithm [16]. In
agreement with a previous publication [17], pixels with SI
above the mean + 6 SD of the normal myocardium were
regarded as enhanced pixels, i.e. pixels of the infarct. The
mean SI of t hese enhanced pix e ls was calcula t ed from
this set of pixels in each image. If no pixels above the
threshold were found, the mean signal intensity of the
infarct was concluded to be equal to that of healthy myo-
cardium. The mean SIE in each pixel was computed by
[18]:
SIE 1 SI SI SI in n =× () ( ) 00 − /,
Figure 1 Timeline of the Study Protocol - Double Infarct Model. Day 0 - MI generation in LAD-supply area. Day 28 - another MI generation in LCx- 
supply area. Day 31 (3 days after the 2nd MI) - CMR session: obtaining LE images with Gd(DTPA), followed by Gd(ABE-DTTA) administration. Day 32 (4 
days after the 2nd MI) - CMR session: obtaining LE images with Gd(ABE-DTTA), followed by TTC, and histology.
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where SIi and SIn are the mean signal intensity in infarct
and normal myocardium, respectively.
Statistical analysis
Results are reported as mean ± SD. Statistical analysis
was carried out by SigmaStat (version 2.03; SPSS Inc,
Chicago, IL, USA). Two-way repeated measures analysis
of variance was used to compare the SIE values among
the six experimental groups. Normal distribution and
equality of variances were tested. Although the test of
normality failed, due to the equality of variances, the
equality of group sizes, and the high power of the per-
formed test (0.985 with α = 0.05), the assumption of the F
test in the two-way ANOVA with repeated measures was
not violated [19]. Since an overall significance (P < 0.05)
was established for rejecting the null hypothesis that the
six groups are not different, pairwise differences between
the groups were assessed by using the Holm-Sidak
method of adjustment for multiple comparisons.
Results
Both the acute (LCx) and four-week old (LAD) infarcts
were visible in Gd(DTPA)-enhanced LE images of all six
dogs. The existence and localization of recent and four-
week old infarct were confirmed by TTC. Histologic eval-
uation confirmed acute infarcts with coagulation necro-
sis, inflammation (mostly mononuclear), and multiple
foci of calcification in the 4 days old infarct areas (Figure
2.). Healing with granulation tissue and early collagen
deposition, and small areas of interstitial fibrosis adjacent
to the late subacute infarct were seen in the four-week old
infarct areas. Gd(ABE-DTTA) did not induce SIE in the
subacute (LAD) infarcts, while the acute (LCx) infarcts
were clearly visible on LE images of all six animals in the
presence of this CA (see examples in Figure 3, 4, and 5).
Mean ± SD SIE values are shown in Table 1 and Figure
6. With Gd(ABE-DTTA), the mean SIE in the areas with
acute infarct was 366 ± 167%, whereas in areas of four-
week old infarcts it was only 24 ± 59%. The difference is
statistically significant (P < 0.05). The mean SIE in four-
week old infarct areas with Gd(ABE-DTTA) did not differ
significantly from SIE of healthy myocardium (P = NS). In
contradistinction, Gd(DTPA) produced similar mean
SIEs in acute (430 ± 124%) and four-week old infarcts
(400 ± 124%, P = NS). Furthermore, the mean SIE values
of neither acute nor four-week old infarcts enhanced with
Gd(DTPA) were statistically different from mean SIE of
acute infarct areas enhanced with Gd(ABE-DTTA).
These data show that Gd(ABE-DTTA) differentiates
between acute and 4 week-old infarcts, and induces
approximately the same SIE in acute infarcts as
Gd(DTPA) does.
Discussion
Gd(ABE-DTTA) was capable of differentiating between
acute and four-week old infarcts as no LE effect was seen
in the latter while one is clearly observable in the former.
Acute MIs can be seen on the LE-CMR images enhanced
with either Gd(DTPA) or Gd(ABE-DTTA). Older MIs are
visible only by Gd(DTPA). Our general observations
show in dogs that the agent's affinity to infarcted myocar-
dial tissue disappears between days 10 and 14 following
acute myocardial infarction. The question of the detailed
kinetics of effect disappearance is currently under investi-
gation.
Magnetic resonance imaging for differentiation between 
new and longstanding MI
Saeed et al. [20] have recently published similar observa-
tions with an intravascular, high molecular weight con-
trast agent, P792, Vistarem (Guerbet Group, Paris,
France). They studied one infarct at two different time-
points in a single MI model. The intravascular agent pro-
duced a LE in the acute, 3 day old infarct but not in the
Figure 2 Double Infarct Histology. Histologic section of a dog LV 32 days following the first (LAD), and 4 days after second (LCx), MI. (A) Acute (LCx) 
MI with coagulation necrosis, inflammation and multiple foci of calcification (40×, Masson's trichrome). (B) Same area at higher magnification. Dying 
myocardial fibers (white arrow) associated with inflammatory cells, Calcium precipitates (white arrowhead) (100×). (C) Late subacute (LAD) MI in the 
same heart with granulation tissue (white arrowhead) and early collagen deposition, interdigitating (white arrow) with viable myofibers (40×, Masson's 
trichrome).Kirschner et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:22
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later, chronic phase, at 8 weeks, after infarction. The
authors have also proven the superiority of their method
over the T2-weighted (T2w) CMR technique (also see
below) for the distinction between acute and chronic
myocardial infarct.
Other methods for the differentiation between new and
longstanding MIs have also been published. In a recent
publication Hillenbrand et al. [21] reported a method
with the combination of Gd(DTPA)-enhanced 1H MR
and  23Na MR. Due to granulation tissue infiltrates and
collagen deposition, the 23Na MR signal intensity in the
MI area showed a significant decrease during infarct
healing. Another approach by Abdel-Aty et al. [22] com-
bined Gd(DTPA)-induced LE with T2-weighted (T2w)
CMR. The distinction was based on an elevated T2w sig-
nal intensity due to edema which is located selectively in
the newly infarcted tissue [22]. The specificity of this
method could be limited by the fact, however, that some-
Figure 3 Differentiation between Acute vs. Subacute Myocardial Infarctions. A: TTC stained photograph of a canine (Dog#1) transversal LV slice 
32 days following the first (LAD) and 4 days after second (LCx) infarct. White arrows point to the acute infarct located in the posterior and postero-
lateral segments (LCx-supply area). Subacute infarct (white arrowheads) is seen on the border of the anteroseptal and anterior segment (LAD-supply 
area). B: Corresponding LE CMR image taken in the presence of Gd(DTPA). This CA does not differentiate between the acute and the subacute infarcts. 
C: Same as B, after the endo- and epicardial contours of the LV muscle had been traced manually D: Image in C thresholded at normal+6SD intensity. 
E: Same CMR image as in B, taken in the presence of Gd(ABE-DTTA) one day following B. Only the posterior and postero-lateral segments, i.e. the acute 
infarct, show LE. The subacute infarct is not highlighted by this agent, thereby differentiating between acute and subacute infarcts. F: Same as E, after 
the endo- and epicardial contours of the LV muscle had been traced manually. G: Image F thresholded at normal+6SD intensity. H: TTC photograph 
of another canine (Dog#2) LV slice 32 days following first (LAD) and 4 days after second (LCx) infarct. White arrows point to the acute (hemorrhagic) 
infarct in the posteromedial papillary muscle (LCx-supply area). Subacute infarct (white arrowheads) is seen predominantly in the anterolateral papil-
lary muscle (LAD-supply area). I: Corresponding LE image with Gd(DTPA). J: Same as I, after the contours of the LV muscle had been traced K: Image J 
thresholded at normal+6SD L: Same CMR image as in I, taken in the presence of Gd(ABE-DTTA) one day following I. Only the acute infarct shows LE. 
The subacute infarct is not highlighted by this agent. M: Same as L, after the contours had been traced N: Image M thresholded at normal+6SD.Kirschner et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:22
http://www.jcmr-online.com/content/12/1/22
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Figure 4 Short Axis LE CMR Image Set -Dog#1. All base-apex slices 
of dog#1 (see also Figure 3). Left column - LE images with Gd(DTPA). 
Right column - LE images with Gd(ABE-DTTA).
Figure 5 Short Axis LE CMR Image Set -Dog#2. All base-apex slices 
of dog#2 (see also Figure 3). Left column - LE images with Gd(DTPA). 
Right column - LE images with Gd(ABE-DTTA).Kirschner et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:22
http://www.jcmr-online.com/content/12/1/22
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times, especially in the case of ongoing residual ischemia,
sustained postinfarction edema can be detected for up to
one year after MI [23]. Kim et al. [24] used contrast
enhanced steady state free precession (SSFP) CMR for the
distinction between recent and chronic MIs. The mean
signal intensity of acute infarct areas was elevated during
SSFP CMR, two minutes after Gd(DTPA) administration.
Chronic infarct regions, however, showed signal intensi-
ties similar to that of normal myocardium. The exact
mechanism of the LE phenomenon is not known to date
even for standard extracellular agents. Increased volume
of distribution, due to sarcolemmal membrane rupture in
acute infarct, and low grade of cellularity with expanded
interstitial collagen matrix of chronic scar tissue, have
been suggested as potential mechanisms for such agents
[4,5,25-27].
Histological basis of the CMR observation
The evolution of MI is a complex pathohistological pro-
cess [28]. Several hypotheses can be brought up to
explain the selective accumulation of Gd(ABE-DTTA)
into acute MIs. The first is linked to the partial intravas-
cular nature of Gd(ABE-DTTA) [10]. Microvascular
damage in an acute infarct [28] could lead to increased
microvascular permeability towards CAs with intravas-
cular behavior [29,30], while the remodeled microvessels
in healing infarcts [20,31] would reduce such permeabil-
ity. Having partial intravascular characteristics [10], the
above mentioned process could increase the wash-in con-
stant of Gd(ABE-DTTA) in acute infarcts, and decrease it
in four-week old infarcts. A second hypothesis may be
attributable to a possible necrosis-avidity of Gd(ABE-
DTTA). There may be binding sites for the CA among the
different elements of acute necrotic tissue such as subcel-
lular compartments (ruptured membrane, cytosol, mito-
chondria), calcium precipitates [28,32], or ingredients of
acute inflammatory reactions, persisting selectively in
acutely infarcted tissue. Thus the progressive, persistent
[10] accumulation in acutely infarcted tissue of Gd(ABE-
DTTA) may be partly due to its partial lipophilic nature
[8], whereby lipids derived from the above mentioned cel-
lular components may trap this CA.
Study limitations
Our study has some limitations. The LE images with the
two different CAs were performed on two consecutive
days. Thus, small differences in selection of the planes of
the short-axis images between the two CMR sessions
cannot be completely excluded. These differences, how-
ever, would not impair the outcome of our studies.
On day 31, Gd(ABE-DTTA) was administered at the
end of the first CMR session. It brings up the possibility,
as Gd(DTPA) (in spite of its short half life time) might not
have been fully cleared from the body yet, that the two
contrast agents could potentially interact with each other.
There is no chemical basis, however, for the assumption
of interaction, and that it could have influenced the late
enhancement phenomenon in the second CMR session,
i.e. 24 hours later. Publications [10,14] already demon-
strated the ability of Gd(ABE-DTTA) to detect acute
infarcts. These publications used a protocol where
Gd(ABE-DTTA) was administered alone.
Gd(ABE-DTTA) needs to be administered 24 hours
before CMR imaging, and this introduces an inconve-
nience in a clinical setting. It may not be convenient (the
cardiology ward and radiology are not necessarily close),
nor practical for answering the urgent clinical question in
a timely fashion. This mode of contrast agent administra-
tion, however, is not unknown in the practice of nuclear
cardiology. For example, there is a protocol for the assess-
Table 1: Contrast Induced by the Two Agents in Acute versus Subacute Infarcts
Gd(ABE-DTTA) Gd(DTPA)
Parameter Acute infarct Subacute infarct Acute infarct Subacute infarct
SIE (%)* 366 ± 166 24 ± 59 431 ± 124 400 ± 124
P value† vs. normal 
myocardium
P < 0.05 NS P < 0.05 P < 0.05
P value vs. Gd(ABE-
DTTA)subacute
P < 0.05 P < 0.05 P < 0.05
P value vs. Gd(ABE-
DTTA)acute
NS NS
P value vs. 
Gd(DTPA)acute
NS
*Mean ± SD (n = 6) signal intensity enhancement (in percent values) by Gd(ABE-DTTA) or Gd(DTPA) in the territory of acute or subacute 
occlusions
†P values pertain to pairwise comparisons by the Holm-Sidak method of the different subgroups.Kirschner et al. Journal of Cardiovascular Magnetic Resonance 2010, 12:22
http://www.jcmr-online.com/content/12/1/22
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ing of myocardial viability with rest redistribution
201Thallium SPECT (Single Photon Emission Computed
Tomography), where repeated delayed imaging is
employed 3-4 h or 24 h following the administration of
the radiotracer [33].
The slow clearance of Gd(ABE-DTTA) from the body
suggests that the time available for undesired physiologi-
cal effects, such as dissociation of Gd from the chelate,
may be considerably longer than is the case for agents
currently approved for human use. It is noteworthy, how-
ever, that Gd(ABE-DTTA)'s short- and long term physio-
logical safety has been reported [11].
Conclusions
In summary, we have shown that LE-CMR with separate
administrations of Gd(DTPA) and Gd(ABE-DTTA) dif-
ferentiates between acute and four-week old MIs in a rep-
erfused, double infarct, canine model.
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